For example, if the RP interval is significantly shorter during ventricular pacing than during tachycardia, the P wave is not likely to be retrograde and the diagnosis is likely to be sinus or ectopic atrial tachycardia.
In a follow-up period from 90 days to 24 months, recurrence of symptomatic or asymptomatic paroxysmal atrial fibrillation, atrial flutter or atrial tachycardia was detected via intensive heart rhythm monitoring.
The RhythmView system, including the RhythmView console and FIRMap[TM] catheter, is designed to improve patient outcomes by enabling electrophysiologists to view a dynamic representation of the electrical activity of the heart, supporting the diagnosis of and treatment planning for a variety of arrhythmias including atrial flutter, atrial tachycardia, ventricular tachycardia, and atrial fibrillation (AF).
The study results, previously presented at an American Heart Association Scientific Sessions meeting, found that pacemaker patients who have no history of atrial tachycardia (AT) or AF, but do have device-detected arrhythmias, are approximately 2.
The positive pharmacokinetic and pharmacodynamic results from our Australian Phase 1 study suggest to us that MSP-2017 may show efficacy in termination of acute episodes of atrial tachycardia in patients with PSVT.